What question did this study set out to answer?

To design an effective multiepitope reverse vaccine candidate against Trypanosoma cruzi using core proteomics and immunoinformatic approaches.

October 7, 2022VaccinesOpen Access

Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease

View Full Paper

Ask AI

Bookmark

Authors

SISk Injamamul Islam SSSaloa Sanjida SASheikh Sunzid Ahmed

Discussion

Member takes

Overview

Computational study reveals a stable multiepitope vaccine candidate targeting Trypanosoma cruzi, suggesting a viable immunotherapeutic option against Chagas disease.

Key Points

To design an effective multiepitope reverse vaccine candidate against Trypanosoma cruzi using core proteomics and immunoinformatic approaches.
Screened Trypanosoma cruzi core proteomics to predict and select immunodominant, antigenic, soluble, and non-allergenic epitopes.
Modeled the tertiary construct and evaluated molecular docking and molecular dynamics simulations against TLR4, MHC-I, and MHC-II receptors.
Conducted immune profile simulations and performed in silico codon optimization for expression within the Escherichia coli K12 pET28a(+) vector system.
Demonstrated strong binding affinities and significant hydrogen bond interactions between the vaccine construct and TLR4, MHC-I, and MHC-II receptors.
Showed substantial structural compactness and sustained molecular stability throughout molecular dynamics simulations.
Achieved high GC content and codon adaptation index values upon codon optimization, verifying computational cloning feasibility.

Cite This Study

Islam et al. (2022) studied this question.

synapsesocial.com/papers/6a1c03270a1f7575939d5c1a https://doi.org/10.3390/vaccines10101669

View Full Paper

Ask AI

Bookmark

October 7, 2022VaccinesOpen Access

Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease

View Full Paper

Ask AI

Bookmark

Authors

SISk Injamamul Islam SSSaloa Sanjida SASheikh Sunzid Ahmed

Discussion

Member takes

Overview

Computational study reveals a stable multiepitope vaccine candidate targeting Trypanosoma cruzi, suggesting a viable immunotherapeutic option against Chagas disease.

Key Points

To design an effective multiepitope reverse vaccine candidate against Trypanosoma cruzi using core proteomics and immunoinformatic approaches.
Screened Trypanosoma cruzi core proteomics to predict and select immunodominant, antigenic, soluble, and non-allergenic epitopes.
Modeled the tertiary construct and evaluated molecular docking and molecular dynamics simulations against TLR4, MHC-I, and MHC-II receptors.
Conducted immune profile simulations and performed in silico codon optimization for expression within the Escherichia coli K12 pET28a(+) vector system.
Demonstrated strong binding affinities and significant hydrogen bond interactions between the vaccine construct and TLR4, MHC-I, and MHC-II receptors.
Showed substantial structural compactness and sustained molecular stability throughout molecular dynamics simulations.
Achieved high GC content and codon adaptation index values upon codon optimization, verifying computational cloning feasibility.

Cite This Study

Islam et al. (2022) studied this question.

synapsesocial.com/papers/6a1c03270a1f7575939d5c1a https://doi.org/10.3390/vaccines10101669

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark